Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07490002 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Neoadjuvant Therapy With Iparomlimab and Tuvonralimab, Lenvatinib and Chemotherapy in Resectable ESCC

StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This is a single-arm, exploratory clinical study.
Trial Details
NCT Number NCT07490002
Lead Sponsor Changhai Hospital
Conditions
(from sponsor)		 Esophageal Squamous Carcinoma
Enrollment 33 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov